Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes,Diabetes, Obesity and Metabolism

当前位置： X-MOL 学术 › Diabetes Obes. Metab. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes
Diabetes, Obesity and Metabolism ( IF 5.4 ) Pub Date : 2021-06-29 , DOI: 10.1111/dom.14477
Daniel R Quast ₁ , Michael A Nauck ₁ , Nina Schenker ₁ , Björn A Menge ₁ , Christoph Kapitza ₂ , Juris J Meier _{1,

3}

Affiliation

To clarify the distinct effects of a long-acting (liraglutide) and a short-acting (lixisenatide) glucagon-like peptide-1 receptor agonist (GLP-1 RA) on macronutrient intake, gastrointestinal side effects and pancreas function.

中文翻译：